FindTrial
Sign In

Hearing evaluation of babies with jaundice

Prospective evaluation of hearing status in neonatal hyperbilirubinemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035944
Enrollment
117
Registered
2021-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs

Interventions

None listed

Sponsors

Akshay Padinharakandy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: newborns and infants with history of healthy term delivery (more than 37 weeks old), near term delivery (35â??37 weeks old), average weight, hyperbilirubinemia (bilirubin more than 15 mg/dl in near term and more than 20 mg/dl in full term delivery ).

Exclusion criteria

Exclusion criteria: presence of neonatal hypoxia, intrauterine infections, sepsis or meningitis, infants with a family history of hearing loss, low birth weight, ototoxic medications such as aminoglycosides, congenital malformations

Design outcomes

Primary

MeasureTime frame
oae resultsTimepoint: at birth, 8 weeks—

Secondary

MeasureTime frame
bera wave changesTimepoint: 8 weeks, 24 weeks—

Countries

India

Contacts

Public ContactAkshay Padinharakandy

Kasturbha Hospital Manipal

akshaypadinharakandy@gmail.com08202922218

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026